We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+16.13%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$118M
AUM Growth
Cap. Flow
+$110M
Cap. Flow %
93.29%
Top 10 Hldgs %
44.14%
Holding
66
New
66
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 76.21%
2 Consumer Staples 3.12%
3 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNMK
26
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.57M 1.33%
+118,338
New +$1.44M
ALGN icon
27
Align Technology
ALGN
$12.1B
$1.55M 1.31%
+27,110
New +$1.46M
LMAT icon
28
LeMaitre Vascular
LMAT
$2.32B
$1.52M 1.29%
+189,406
New +$1.46M
SGNT
29
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.41M 1.2%
+55,619
New +$1.26M
ELGX
30
DELISTED
Endologix Inc
ELGX
$1.32M 1.12%
+7,574
New +$1.3M
MASI
31
DELISTED
Masimo
MASI
$1.3M 1.11%
+44,651
New +$1.25M
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.14M 0.97%
+16,217
New +$1.1M
PETX
33
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.04M 0.88%
+54,289
New +$1.1M
COV
34
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$993K 0.84%
+14,579
New +$949K
ANGO icon
35
AngioDynamics
ANGO
$611M
$976K 0.83%
+56,863
New +$875K
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$121B
$967K 0.82%
+13,019
New +$907K
OREX
37
DELISTED
Orexigen Therapeutics, Inc.
OREX
$962K 0.82%
+17,080
New +$960K
VVUS
38
DELISTED
Vivus Inc
VVUS
$887K 0.75%
+9,767
New +$943K
SURG
39
DELISTED
SYNERGETICS USA, INC.
SURG
$851K 0.72%
+234,999
New +$961K
CYTK icon
40
Cytokinetics
CYTK
$10.5B
$848K 0.72%
+130,451
New +$857K
HTWR
41
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$843K 0.71%
+8,977
New +$759K
THOR
42
DELISTED
THORATEC CORPORATION
THOR
$787K 0.67%
+21,506
New +$844K
ENDP
43
DELISTED
Endo International plc
ENDP
$616K 0.52%
+9,125
New +$521K
NVS icon
44
Novartis
NVS
$297B
$488K 0.41%
+6,774
New +$471K
FRX
45
DELISTED
FOREST LABORATORIES INC
FRX
$458K 0.39%
+7,635
New +$384K
BMY icon
46
Bristol-Myers Squibb
BMY
$133B
$441K 0.37%
+8,290
New +$422K
UTHR icon
47
United Therapeutics
UTHR
$25.8B
$432K 0.37%
+3,820
New +$344K
VTRS icon
48
Viatris
VTRS
$20.4B
$424K 0.36%
+9,775
New +$402K
ELV icon
49
Elevance Health
ELV
$81.5B
$378K 0.32%
+4,095
New +$364K
STJ
50
DELISTED
St Jude Medical
STJ
$375K 0.32%
+6,055
New +$351K

Similar funds

First Light Asset Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for First Light Asset Management, which disclosed 66 positions worth $118M. Its ten largest holdings account for 44% of the portfolio.

Its largest position is AtriCure: 599,048 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, followed by Consumer Staples and Financials.

  • First Light Asset Management's largest Q4 2013 buy was AtriCure: 599,048 shares worth $11.2M.
  • First Light Asset Management's ten largest holdings make up 44% of its $118M portfolio in Q4 2013.
  • First Light Asset Management disclosed 66 positions in Q4 2013, its first 13F filing on record.

Based on First Light Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.